jak2 | 20771
JAK2 p.V617F mutation diagnostic
Keywords
Chronic myeloid leukemia, CML, Essential thrombocythemia, essential thrombocytosis, Leukocytosis, MPN, Myeloproliferation, Myleoproliferative Neoplasm, osteomyelofibrosis, polycythemia, Polycythemia vera, Polyglobulia, Splenomegaly
| Material |
|
|
| Note |
Since in rare cases there may also be indications of hereditary changes, the GUMG (Federal Law on Genetic Testing in Humans) provides for the patient to be informed accordingly (see www.viollier.ch/en/SGMG_consent). |
|
| Min. quantity | 4 mL | |
| Stability | 1 day / 18-25°C; 4 days / 2-8°C | |
| Duration | 3 days | |
| Frequency | 2 x per week | |
| Method | digital PCR | |
| Price | CHF 312.30 | |
| Tariff | 312.30 TP |
Reference values
| Value | Sex |
|---|---|
| negative | f+m |
Team of consultants
|
PD, MD
Giuseppe Colucci
FMH internal medicine, hematology, FAMH Specialist in laboratory medicine
|
FMH internal medicine, hematology, FAMH Specialist in laboratory medicine | T |
|
|
PhD
Christian Kalberer
FAMH Specialist in laboratory medicine, main field hematology
|
FAMH Specialist in laboratory medicine, main field hematology | T |
|
|
MD
Kaoutar Hamouda
General Medicine, Candidate FAMH Specialist in laboratory medicine, main field medical hematology
|
General Medicine, Candidate FAMH Specialist in laboratory medicine, main field medical hematology | T |
|
|
MD FMH hematology, FAMH Specialist in laboratory medicine
Maurice Redondo
Head of Routine laboratories
|
Head of Routine laboratories | T |
|
|
MD
Boris E. Schleiffenbaum
FMH internal medicine, hematology, FAMH Specialist in laboratory medicine, main field hematology
|
FMH internal medicine, hematology, FAMH Specialist in laboratory medicine, main field hematology | T |
|